A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

NCT05595642 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1290

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Astegolimab
DRUG: Placebo

Sponsor

Hoffmann-La Roche